Thrombospondin-1 derived peptides and treatment methods

Details for Australian Patent Application No. 2006261911 (hide)

Owner Cadila Healthcare Limited

Inventors Agah, Ramtin

Agent Griffith Hack

Pub. Number AU-B-2006261911

PCT Pub. Number WO2007/002534

Priority 60/693,574 24.06.05 US

Filing date 23 June 2006

Wipo publication date 4 January 2007

Acceptance publication date 13 May 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 2/00 (2006.01) Peptides of undefined number of amino acids

C07K 4/00 (2006.01) Peptides having up to 20 amino acids in an undefined or only partially defined sequence

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/002534 Priority application(s): WO2007/002534

10 December 2009 Assignment before Grant

  Agah, Ramtin The application has been assigned to Cadila Healthcare Limited

13 May 2010 Application Accepted

  Published as AU-B-2006261911

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261913-Methods of adjusting sales plans

2006261909-Cell lines for expressing enzyme useful in the preparation of amidated products